Mylan Current Ratio 2006-2019 | MYL

Current and historical current ratio for Mylan (MYL) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Mylan current ratio for the three months ending September 30, 2019 was 1.43.
Mylan Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $6.65B $4.65B 1.43
2019-06-30 $6.27B $4.56B 1.37
2019-03-31 $6.26B $4.16B 1.51
2018-12-31 $6.37B $4.59B 1.39
2018-09-30 $6.54B $5.18B 1.26
2018-06-30 $6.30B $4.86B 1.30
2018-03-31 $6.76B $6.39B 1.06
2017-12-31 $7.21B $6.39B 1.13
2017-09-30 $7.27B $4.98B 1.46
2017-06-30 $6.97B $5.17B 1.35
2017-03-31 $7.07B $4.52B 1.56
2016-12-31 $7.52B $5.04B 1.49
2016-09-30 $7.97B $9.55B 0.83
2016-06-30 $12.19B $3.78B 3.23
2016-03-31 $6.63B $3.96B 1.67
2015-12-31 $6.47B $4.12B 1.57
2015-09-30 $6.49B $3.68B 1.76
2015-06-30 $7.89B $5.37B 1.47
2015-03-31 $7.43B $5.29B 1.40
2014-12-31 $6.44B $5.30B 1.21
2014-09-30 $5.82B $4.47B 1.30
2014-06-30 $4.48B $2.60B 1.72
2014-03-31 $4.34B $2.65B 1.64
2013-12-31 $4.47B $2.96B 1.51
2013-09-30 $4.34B $2.56B 1.70
2013-06-30 $4.21B $2.33B 1.81
2013-03-31 $3.95B $2.28B 1.73
2012-12-31 $3.90B $2.19B 1.78
2012-09-30 $3.75B $2.17B 1.73
2012-06-30 $3.75B $2.16B 1.73
2012-03-31 $3.74B $2.11B 1.77
2011-12-31 $3.57B $2.56B 1.39
2011-09-30 $3.61B $2.38B 1.52
2011-06-30 $3.76B $2.52B 1.49
2011-03-31 $3.76B $2.39B 1.57
2010-12-31 $3.56B $1.81B 1.97
2010-09-30 $3.46B $1.72B 2.01
2010-06-30 $3.63B $1.63B 2.23
2010-03-31 $3.36B $1.64B 2.05
2009-12-31 $3.29B $1.72B 1.91
2009-09-30 $3.26B $1.58B 2.06
2009-06-30 $3.02B $1.42B 2.13
2009-03-31 $2.91B $1.34B 2.17
2008-12-31 $3.18B $1.55B 2.06
2008-09-30 $3.42B $1.82B 1.88
2008-06-30 $3.48B $2.11B 1.65
2008-03-31 $3.49B $2.22B 1.57
2007-12-31 $3.06B $2.00B 1.53
2007-09-30 $2.62B $0.77B 3.42
2007-06-30 $2.62B $0.83B 3.16
2007-03-31 $2.41B $0.70B 3.44
2006-12-31 $1.28B $0.29B 4.46
2006-09-30 $1.33B $0.26B 5.13
2006-06-30 $1.29B $0.29B 4.41
2006-03-31 $1.19B $0.27B 4.49
2005-12-31 $1.17B $0.26B 4.45
2005-09-30 $1.27B $0.27B 4.70
2005-06-30 $1.57B $0.26B 5.93
2005-03-31 $1.53B $0.25B 6.23
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.956B $11.434B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.181B 11.15
Teva Pharmaceutical Industries (TEVA) Israel $10.834B 4.41
Bausch Health Cos (BHC) Canada $10.259B 6.77
Dr Reddy's Laboratories (RDY) India $6.698B 17.57
ASPEN PHARMACR (APNHY) South Africa $3.391B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.198B 11.59
Amphastar Pharmaceuticals (AMPH) United States $0.888B 46.15
Homology Medicines (FIXX) United States $0.800B 0.00
Voyager Therapeutics (VYGR) United States $0.518B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.428B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.287B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.180B 0.00
Sol-Gel Technologies (SLGL) Israel $0.158B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
CymaBay Therapeutics (CBAY) United States $0.120B 0.00
Teligent (TLGT) United States $0.033B 0.00